22nd Century Group Inc (XXII) Email Format

Biotechnology ResearchNew York, United States2-10 Employees

22nd Century Group Inc. is a small biotechnology company based in Williamsville, New York, focused on biotechnology research with a specific emphasis on tobacco products and nicotine reduction. The company develops reduced-nicotine cigarette options intended to lower nicotine exposure as part of its product strategy, and it aims to broaden its distribution through national retailers. Its work sits in the biotech and tobacco products space, reflecting a targeted approach to nicotine management. In May 2026, the company announced the launch and initial shipments of its Pinnacle VLN reduced-nicotine cigarette brand, with distribution planned for about 150 stores in the metro New York area and northern New Jersey. The firm’s activities reflect ongoing efforts to expand its Pinnacle line and broaden its retail footprint in the United States. The company trades on Nasdaq under XXII.

Sign up for free to view info

Company overview Employee directory